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Downregulation of phosphodiesterase PDE2A activity in heart failure
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Cyclic nucleotide phosphodiesterases (PDEs) comprise a family of cyclic-
nucleotide hydrolysing enzymes, controlling cAMP and cGMP levels. Among 
them, the PDE2A isoform is a dual speci¿ city enzyme hydrolyzing both 
cAMP and cGMP. PDE2A is unique in being allosterically activated by cGMP, 
resulting in enhanced cAMP hydrolysis. This characteristic of PDE2A allows 
a negative cross-talk between both signaling pathways. Here, we hypothesized 
that alterations in PDE2A may contribute to the imbalance between cAMP- 
and cGMP-signaling pathways in failing hearts.
PDE2 activity was measured by radioimmunoassay in left ventricular (LV) 
myocardium from non-failing donor-hearts (NF; n=6) and from patients with 
terminal heart failure (hHF, n=12) caused by either ischemic (ICM; n=6) or 
dilated cardiomyopathy (DCM; n=6). PDE2 activity was also measured in LV 
from dogs subjected to rapid-pacing induced HF (dHF; n=4) or from Sham-
operated controls (Sham; n=4). We found a signi¿ cant decrease in cGMP-
PDE2 activity in dHF (101 pmol/min/mg in dHF vs. 117 in Sham, p<0.05). 
In human samples, the cGMP-PDE2 activity was strongly reduced only in 
the ICM group (43 pmol/min/mg in ICM vs. 94 in NF, p<0.05) and tended 
to decrease in DCM also, although not in a statistically signi¿ cant manner.
To compensate for the decreased PDE2 activity in HF, we used an adeno-
virus encoding the mouse membrane-bound PDE2A2 isoform (Ad-PDE2A2). 
Intracellular cAMP ([cAMP]i) was measured in adult rat ventricular myocytes 
(ARVMs) using the FRET-based probe Epac2-camps. The [cAMP]i response 
to the E-adrenergic agonist isoprenaline (100 nM, 15s application) was lower 
in ARVMs infected with Ad-PDE2A2 than in control myocytes, and was res-
tored upon PDE2 inhibition with 100 nM Bay 60-7550, a PDE2 inhibitor. 
Ongoing efforts to understand the pathophysiological consequences of altered 
PDE2A activity in the failing heart include the generation of a PDE2A trans-
genic mouse model and screening for speci¿ c PDE2 activators.
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Serotonin (5-HT) participates in the development of cardiac hypertrophy 
through 5-HT2A serotonin receptors, whose regulation is not fully understood. 
Caveolae are specialized plasma membrane domains that modulate signal 
transduction elicited by membrane-bound receptors. Because caveolin-3 plays 
a critical role in cardiac hypertrophy, we hypothesized that this structural com-
ponent of cardiac caveolae could be an important regulator of 5-HT2A receptor 
signalling leading to cardiac cell hypertrophy.
We observed that, in ventricular myocardium of mice subjected to pres-
sure overload induced by thoracic aortic constriction, there was a signi¿ cant 
increase in 5-HT2A receptors expression accompanied by a downregulation of 
caveolin-3 expression compared to sham operated animals. Therefore, we ana-
lyzed whether down regulation of caveolin-3 expression could have functional 
consequences on 5-HT2A receptors-mediated hypertrophy. We demonstrate that 
caveolin-3 knockdown by siRNA enhances the increase in cell surface area, 
protein synthesis and hypertrophic gene program induced by 5-HT2A receptors 
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Lack of Microsomal Prostaglandin E2 Synthase-1 in bone marrow 
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Microsomal prostaglandin E2 synthase-1 (mPGES-1), encoded by the 
Ptges gene, functions downstream from COX-2 in PGE2 biosynthesis. 
After myocardial infarction (MI), leukocytes in the infarct zone express 
mPGES-1. In this study, we de¿ ne the role of mPGES-1 in bone marrow 
(BM) derived leukocytes in the regulation of LV remodelling after MI. To 
generate chimeras, irradiated Ptges+/+ mice were transplanted with BM 
from Ptges+/+ (Ptges+/+ BM+/+) or Ptges-/- (Ptges+/+ BM-/-) mice. MI 
was induced by left coronary artery ligation. Eicosanoid and mRNA levels 
were measured by LC/MS/MS and quantitative real time PCR, respectively. 
Left ventricular (LV) function was assessed by echocardiography and pres-
sure conductance catheterization. There was no baseline difference in LV 
dimensions or function between chimeras. 28 days after MI, Ptges+/+ BM-/- 
mice had larger LV volumes, lower fractional shortening, worse LV sys-
tolic and diastolic function, higher LV end diastolic pressure and increased 
mortality (Table 1). There was no difference in the volume of infarcted LV 
between chimeras. Levels of eicosanoids and expression of COX-1 mRNA 
was higher in the infarct zone of Ptges+/+ BM-/- mice 7 days after MI. 
These data show that mPGES-1 negatively regulates COX-1 expression in 
leukocytes. Selective deletion of mPGES-1 in leukocytes increases COX-1 
expression and eicosanoid biosynthesis, and results in impaired LV remo-
delling and increased mortality after MI. Inhibiting mPGES-1, a therapy 
proposed for patients with inÀ ammatory diseases, may adversely affect LV 
remodelling after MI.
Comparisons at day 28 unless 
otherwise speci¿ ed
Ptges+/+BM+/+ Ptges+/+BM+/- p
LV volume (ml) 13.83±0.75 19.56±1.54 <0.01J
Fractional shortening (%) 22±3 13±1 <0.001a
dP/dT max (x103) 11.2±0.3 9.9±0.3 <0.05a
dP/dT min (x103) -8.4±0.2 -7.3±0.2 <0.05a
End diastolic pre. (mmHg) 11.2±1.3 15.7±1.1 <0.05a
COX-1/GAPDH mRNA in 
infarct zone day 7 post MI
8.19±0.99 11.79±1.13 <0.05a
Survival proportion (%) 94 76 0.04E
Infarct site (% if LV) 33.4±2.1 35.9±1.3 0.32J
a 2 Way ANOVA with Bonferroni’s post tests. b Logrank Test. y Student T Test.
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of cytochrome-c oxidase was detected by blue native PAGE, and interaction 
between subunit IV of cytochrome-c oxidase and PHB2 was greatly reduced 
(Figure A). Moreover, depletion of SphK2 or PHB2 led to a dysfunction in 
mitochondrial respiration through cytochrome-c oxidase (Figure B). Our data 
point to a new action of S1P in mitochondria and suggest that interaction of 
S1P with homomeric PHB2 is important for cytochrome-c oxidase assembly 
and mitochondrial respiration.
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Introduction: Intermittent hypoxia (IH)-as a model of obstructive sleep 
apnoea syndrome -is known to induce increase of systemic blood pressure 
(BP) but not consistently cardiac hypertrophy in rodents. The aim of the 
present study was to evaluate the effect of IH exposure 1) on cardiac workload 
and hypertrophy; 2) on mitochondrial function, the main energy provider in 
cardiomyocytes.
Methods: Rats were exposed to IH (21-5% FiO2, 60s cycle, 8h/d) or air for 
5 or 35 days. Echocardiography and intraventricular pressure allowed cardiac 
function evaluation. Arterial BP was measured by catheterization of carotid 
artery. RT-qPCR on left (LV) and right (RV) ventricles enabled mRNA quanti-
in cardiac cells. We also provide evidence that 5-HT2A receptors interact with 
caveolin-3 upon agonist stimulation and traf¿ c into caveolae membrane micro-
domains. In addition, the p42/p44 MAPK and Akt hypertrophic pathways are 
not affected by caveolin-3 siRNA silencing. On the other hand, we demons-
trate for the ¿ rst time that caveolin-3 and caveolae are negative regulators of 
the calcineurin/nuclear factor of activated T cells (NFAT) pathway activated 
by 5-HT2A receptors.
Taken together, our ¿ ndings establish caveolin-3 as an important regulator 
of hypertrophic response induced by 5-HT2A receptors.
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High-density lipoprotein (HDL) has been reported to be cardioprotec-
tive independently from its cholesterol transport activity. Phosphorylation of 
connexin 43 (Cx43), the predominant gap junction protein in ventricular myo-
cardium, at Serine-368 is cardioprotective during preconditioning. Therefore, 
we hypothesized that Cx43 gap junction channels may be implicated in the 
cardioprotective properties of HDL. Neonatal rat cardiomyocytes were iso-
lated and treated with different doses of HDL for 5min to 24hrs. Cx43 
expression and phosphorylation was evaluated by Western blotting and immu-
noÀ uorescence. Intercellular communication between cardiomyocytes was 
evaluated by microinjection of the À uorescent dye Lucifer Yellow. We found 
that HDL promoted phosphorylation of Cx43 in a time-dependent manner 
with the highest ef¿ ciency at 400ug/ml and 5min. Involvement of various 
kinases was then studied by pre-treating cardiomyocytes with speci¿ c inhi-
bitors. We observed that HDL-induced Cx43 phosphorylation was inhibited 
by the pre-treatment with the PKC inhibitor chelerythrin (5 uM), but not 
inÀ uenced by pre-treatment with inhibitors against p38-MAPK, JNK, ERK 
or PI3K/Akt. Using phosphorylation site-speci¿ c antibodies, we showed that 
HDL-dependent phosphorylation involved Ser368 in the C-terminus of Cx43. 
Finally, HDL decreased dye coupling (control=12±2 cells, HDL=5±1 cells, 
n=17-19, p<0.01), and this effect was reversed by pre-incubating cardiomyo-
cytes with the PKC inhibitor (14±2 cells, n=11, p<0.01). In conclusion, short-
term treatment with HDL induces phosphorylation of Cx43 at Ser368, which 
in turn, decreases intercellular communication between neonatal cardiomyo-
cytes, thereby possibly preventing the spread of damaging factors. These 
results link Cx43 for the ¿ rst time to the cardioprotective effects of HDL. A 
better understanding of molecular pathways involved in cardioprotection may 
lead to the identi¿ cation of new molecules for the treatment of heart disease.
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The potent lipid mediator sphingosine-1-phosphate (S1P) regulates diverse 
physiological processes by binding to 5 speci¿ c GPCRs, although it also has 
intracellular targets. Here, we demonstrate that S1P, produced in the mito-
chondria mainly by sphingosine kinase 2 (SphK2), binds with high af¿ nity 
and speci¿ city to prohibitin 2 (PHB2), a highly conserved protein that regu-
lates mitochondrial assembly and function. In contrast, S1P did not bind to 
the closely related protein PHB1, which forms large, multimeric complexes 
with PHB2. In heart mitochondria from SphK2-null mice, a new aberrant band 
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Ischemic postconditioning (IPost) protects the heart against prolonged 
lethal ischemia by activating a cardioprotective signaling cascade involving 
Akt, GSK3beta, and mitochondrial ATP sensitive potassium channel (mito-
KATP). We have recently shown that preconditioning involves a crosstalk 
between an embryonic developmental Wnt pathway and a survival mTOR 
pathway, which seems to converge on GSK3beta. Here we propose to address 
the implication of this crosstalk during postconditioning.
Two models of postconditioning were used on isolated Langendorff-
perfused mice hearts after 45 min stabilization followed by 40 min ischemia: 
IPost with ten cycles of 5 sec ischemia / 5 sec reperfusion and pharmacolo-
gical postconditioning (PPost) by perfusion with diazoxide, a mitoKATP acti-
vator. IPost, like PPost, induced an inhibition/phosphorylation of GSK3beta 
through Akt activation. This was correlated with a signi¿ cant reduction of 
infarct size after 40 min ischemia followed by 120 min reperfusion as com-
pared to control, blocked by 5-HD co-perfusion. Cardioprotection and signa-
ling of postconditioning were impaired in GSK3 knock-in mice. However, 
cardiac overexpression of sFRP1, a Wnt antagonist, impairing preconditio-
ning through GSK3beta, was unable to abolish cardioprotection afforded by 
postconditioning.
Unlike preconditioning, postconditioning did not induce the mTOR sur-
vival pathway: neither phosphorylation of mTOR nor of its targets p70S6K 
and 4EBP1 were observed. This was in good agreement with the inability of 
rapamycin, an inhibitor of mTOR, to abolish postconditioning.
In mice, postconditioning signaling seems to differ from the preconditio-
ning pathway. Indeed, we evidenced that mTOR survival pathway and Wnt 
pathway are not implicated in postconditioning. Despite these discrepancies, 
Akt, GSK3beta and the mitoKATP are common targets of postconditioning 
and preconditioning.
¿ cation of ANP, BNP, MCIP-1, PGC-1D, D and E-MHC. Mitochondrial func-
tion was assessed using oxygraphy on saponin permeabilized ¿ bers in situ.
Results: IH induced an increase of arterial BP. Cardiac hypertrophy was 
demonstrated at 5d and 35d IH. RV analysis revealed increase in both mass 
and volume after 35d-IH, and LV only a greater volume. RV hypertrophy 
was associated with a signi¿ cant increase in intraventricular pressure and 
dP/dt traducing a better RV contraction. Echocardiography measurements in 
LV demonstrated also a better contraction. mRNA expression of ANP, BNP 
and MCIP-1 were increased in RV whereas unchanged in LV. In both ven-
tricles, E-MHC was increased, and PGC-1D decreased whilst mitochondrial 
density and basal oxidative metabolism conserved. After 35d-IH in both LV 
and RV maximal O2 consumption was lower traducing a global electron À ux 
decrease thorough the mitochondrial respiratory chain when coupled to the 
ATPsynthetase.
Conclusion: Increased systemic BP was accompanied by cardiac hyper-
trophy with higher intraventricular pressures and distinct hypertrophy patterns 
in LV and RV. This IH-induced cardiac hypertrophy was associated with func-
tional mitochondrial alterations and down regulation of PGC-1D in both ven-
tricles that could be in favour of a future decompensate state.
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